Unick George Jay, Ciccarone Daniel
University of Maryland, School of Social Work, United States.
University of California San Francisco, Family and Community Medicine, United States.
Int J Drug Policy. 2017 Aug;46:112-119. doi: 10.1016/j.drugpo.2017.06.003. Epub 2017 Jul 5.
US opioid overdose death rates have increased between 2000 and 2014. While, the increase in prescription opioid use has been linked to the increase in heroin use, there are reasons to view this relationship as a partial explanation for the recent increase in heroin-related harms. This study documents the differences in trends in prescription opioid overdose-related (POD) and heroin overdose-related (HOD) hospitalizations.
Data come from the National Inpatient Sample (NIS) for the years 2000 through 2014. POD and HOD hospitalizations were abstracted from ICD-9 codes. Rates of POD and HOD by census region and census division were constructed along with separate rates for age and race. Regression analysis analyzing trends across region were estimated along with graphs for documenting differences in POD and HOD rates.
POD hospitalization rates were highest in the South and lowest in the Northeast. HOD hospitalization rates were highest in the Northeast region and grew the fastest in the Midwest. There was statistically significant heterogeneity in HOD trends but not POD trends across the four regions between 2000 and 2014. Between 2012 and 2014 POD rates decreased in eight of the nine census divisions, with only New England showing an increase. HOD hospitalization rates increased in all nine census divisions between 2012 and 2014. Both POD and HOD rates show different demographic patterns across the nine census divisions.
Comparing POD and HOD hospitalization trends reveals significant disparities in geographic as well as demographic distributions. These epidemics are evolving and the simple opioid-to-heroin transition story is both supported and challenged by this paper. The opioid pill, heroin and fentanyl crises are intertwined yet increasingly have drivers and outcomes that support examining them as distinct. Addressing these complex and interrelated epidemics will require innovative public health research and interventions which need to consider local and regional contexts.
2000年至2014年间,美国阿片类药物过量致死率有所上升。虽然处方阿片类药物使用的增加与海洛因使用的增加有关,但有理由认为这种关系只是近期海洛因相关危害增加的部分原因。本研究记录了处方阿片类药物过量相关(POD)和海洛因过量相关(HOD)住院趋势的差异。
数据来自2000年至2014年的全国住院患者样本(NIS)。POD和HOD住院病例从ICD - 9编码中提取。构建了按普查区域和普查分区划分的POD和HOD发生率,以及按年龄和种族划分的单独发生率。估计了分析各区域趋势的回归分析,并绘制了记录POD和HOD发生率差异的图表。
POD住院率在南部最高,在东北部最低。HOD住院率在东北地区最高,在中西部增长最快。2000年至2014年期间,四个区域的HOD趋势存在统计学上的显著异质性,但POD趋势不存在。2012年至2014年期间,九个普查分区中有八个的POD发生率下降,只有新英格兰地区呈上升趋势。2012年至2014年期间,所有九个普查分区的HOD住院率均上升。POD和HOD发生率在九个普查分区中均呈现出不同的人口统计学模式。
比较POD和HOD住院趋势可发现地理和人口分布方面存在显著差异。这些流行病正在演变,本文既支持又质疑简单的阿片类药物到海洛因转变的说法。阿片类药丸、海洛因和芬太尼危机相互交织,但越来越具有各自不同的驱动因素和结果,需要将它们分开审视。应对这些复杂且相互关联的流行病需要创新的公共卫生研究和干预措施,这需要考虑当地和区域背景。